Related references
Note: Only part of the references are listed.Immune checkpoint inhibitor-related cholangiopathy: Novel clinicopathological description of a multi-centre cohort
Philip Berry et al.
LIVER INTERNATIONAL (2023)
Immune-related Liver Injury is a Poor Prognostic Factor in Patients with Nonsmall Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
Takafumi Yamamoto et al.
CANCER INVESTIGATION (2022)
Pembrolizumab-related cholangitis with multiple fatal liver abscesses after endoscopic biliary drainage: a case report and review of the literature
Hitomi Hori et al.
CLINICAL JOURNAL OF GASTROENTEROLOGY (2022)
A case of antiprogrammed death-ligand 1 antibody-induced multisystem immune-related adverse events with pancreatitis and steroid-resistant sclerosing cholangitis
Takafumi Yamamoto et al.
JOURNAL OF DIGESTIVE DISEASES (2022)
Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer
Yingying Yu et al.
FRONTIERS IN ONCOLOGY (2022)
Personalized Cytokine-Directed Therapy With Tocilizumab for Refractory Immune Checkpoint Inhibitor-Related Cholangiohepatitis
Laura Moi et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Inflammatory markers in autoimmunity induced by checkpoint inhibitors
Beate Husain et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies
Takanori Ito et al.
HEPATOLOGY INTERNATIONAL (2021)
Comparison of clinical features between immune-related sclerosing cholangitis and hepatitis
Masaki Takinami et al.
INVESTIGATIONAL NEW DRUGS (2021)
Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies
Kazuyuki Mizuno et al.
JOURNAL OF GASTROENTEROLOGY (2020)
Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review
Takumi Onoyama et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Hepatotoxicity From Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation
Thoetchai (Bee) Peeraphatdit et al.
HEPATOLOGY (2020)
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance
Emanuel Raschi et al.
TARGETED ONCOLOGY (2020)
Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors
Eleonora De Martin et al.
JHEP REPORTS (2020)
Secondary sclerosing cholangitis with hemobilia induced by pembrolizumab: Case report and review of published work
Yudai Koya et al.
HEPATOLOGY RESEARCH (2019)
EASL Clinical Practice Guidelines: Drug-induced liver injury
Raul J. Andrade et al.
JOURNAL OF HEPATOLOGY (2019)
Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non-Small-Cell Lung Cancer Who Received Programmed Death 1 Inhibitors
Jun Fukihara et al.
CLINICAL LUNG CANCER (2019)
C-reactive protein as an early marker of immune-related adverse events
Amir-Reza Abolhassani et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Immunotherapy-related hepatitis: real-world experience from a tertiary centre
Vincent Cheung et al.
FRONTLINE GASTROENTEROLOGY (2019)
A case of nivolumab-related cholangitis and literature review: how to look for the right tools for a correct diagnosis of this rare immune-related adverse event
Francesco Gelsomino et al.
INVESTIGATIONAL NEW DRUGS (2018)
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors
Eleonora De Martin et al.
JOURNAL OF HEPATOLOGY (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Bile duct obstruction in a patient treated with nivolumab as second-line chemotherapy for advanced non-small-cell lung cancer: a case report
Jumpei Kashima et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer
Hisato Kawakami et al.
INVESTIGATIONAL NEW DRUGS (2017)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Case Definition and Phenotype Standardization in Drug-Induced Liver Injury
G. P. Aithal et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)